Christopher Hite sold $6M of RPRX stock

Christopher Hite, EVP & Chairman, Partnering of Royalty Pharma plc (RPRX), sold 100,000 shares of RPRX stock worth $6M, per an SEC Form 4 filed Aug 19, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Aug 18, 2026, 1 day before it was made public.

RPRX has moved +15.5% since the trade date, from $59.69 to $68.97 (Nov 12, 2026 close).